Taking people in GermanyPhase 1
Testing SHR-3167 Safety and Blood Levels in Type 2 Diabetes
Tests how the body handles repeated doses of SHR-3167 in adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: An Open-Label, Controlled, Multiple-Dose Phase I Clinical Trial Evaluating the Steady-State Pharmacokinetics, Pharmacodynamics and Safety of SHR-3167 in Subjects With Type 2 Diabetes
Key facts
- Where
- Neuss, GermanySee the site
- Phase
- Phase 1
Where in Germany
- PROFIL Institut fuer Stoffwechselforschung GmbHNeuss, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Jiangsu Hengrui Pharmaceuticals Co. Ltd.
- Trial code
- EU 2026-525932-40-00
- Record updated
- 18 September 2026